Prostate-specific PTen deletion in mice activates inflammatory microRNA expression pathways in the epithelium early in hyperplasia development

Oncogenesis
D Alwyn DartW G Jiang

Abstract

PTen loss is one of the most frequent events in prostate cancer both at the initiation stage and during late stage metastatic development. The mouse model of prostate-specific probasin-mediated Pten deletion leads to prostate intraepithelial neoplasia (PIN) leading to adenocarcinoma. Using this model, we analysed the miR and mRNA transcriptome profile of Pten -/- PIN versus wild type age-matched prostate tissues and analysed the effects of Pten loss on miR expression in the early neoplastic process. At the PIN stage, Pten loss significantly changed the expression of over 20 miRNAs and over 4000 genes. The observed miR expression indicated a strong immunological cohort, which is seen in many human and mouse cancers and is thought to derive from infiltrating B and T immune cells. However, upon in situ hybridisation, these immunologically related miRs did not correlate with immune cell location, and emanated from the prostate epithelium itself and not from the associated immune cells present. Growing Pten -/- prostate cells in culture showed that the overexpressed miRNAs seen in Pten -/- were directly in response to the overactive PI3 kinase pathway and were in part responsible in reducing target gene expression levels. Inhibition...Continue Reading

References

May 26, 1999·Proceedings of the National Academy of Sciences of the United States of America·H SunH Wu
Mar 15, 2001·Current Opinion in Cell Biology·J N Ihle
Jun 16, 2001·Seminars in Cancer Biology·W J HussN M Greenberg
Aug 16, 2001·Proceedings of the National Academy of Sciences of the United States of America·K PodsypaninaR Parsons
Feb 21, 2002·Proceedings of the National Academy of Sciences of the United States of America·Minjung J KimCory Abate-Shen
Feb 8, 2006·Proceedings of the National Academy of Sciences of the United States of America·Stefano VoliniaCarlo M Croce
Aug 4, 2006·Proceedings of the National Academy of Sciences of the United States of America·Konstantin D TaganovDavid Baltimore
Sep 7, 2006·Endocrine-related Cancer·K S Kimbro, J W Simons
Jan 24, 2007·Proceedings of the National Academy of Sciences of the United States of America·Ryan M O'ConnellDavid Baltimore
Feb 9, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J FerlayP Boyle
Nov 10, 2007·Nucleic Acids Research·Sam Griffiths-JonesAnton J Enright
Feb 13, 2008·Proceedings of the National Academy of Sciences of the United States of America·Brooke M EmerlingNavdeep S Chandel
May 17, 2008·The American Journal of Pathology·Junaid AbdulghaniMarja T Nevalainen
Jun 3, 2008·Nature Methods·Ali MortazaviBarbara Wold
Jul 30, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Debashis SarkerJohann S de Bono
Jun 29, 2010·Cancer Cell·Barry S TaylorWilliam L Gerald
Aug 26, 2010·Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B·Shengle ZhangChristine Fuller
Apr 27, 2011·Current Urology Reports·Bilal ChughtaiSteven Kaplan
Jul 5, 2011·Blood·Ryan M O'ConnellDinesh S Rao
Jan 3, 2012·Nucleic Acids Research·Robert S HudsonStefan Ambs
Apr 5, 2012·Nature Reviews. Molecular Cell Biology·Min Sup SongPier Paolo Pandolfi
Apr 17, 2012·Human Molecular Genetics·Claire E FletcherCharlotte L Bevan
Jul 4, 2012·Proceedings of the National Academy of Sciences of the United States of America·Muller FabbriCarlo M Croce
Nov 20, 2012·Current Opinion in Urology·Yakup BostanciBob Djavan
Jan 9, 2013·RNA Biology·Muller FabbriCarlo M Croce
Nov 7, 2013·Physiological Genomics·Qing CaoTing-Ting Huang

❮ Previous
Next ❯

Methods Mentioned

BETA
surgical resections
RNAseq
pulldown
PCR
RNA-Seq
chip
Pull Down

Software Mentioned

Access
Torrent Suite
STAR
Targetscan
Partek
Partek Genomic Suite
RNAseq

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.